Page last updated: 2024-12-07

d-biotin-d-sulfoxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

d-Biotin-d-sulfoxide is a sulfur-containing analog of biotin, a vitamin crucial for various metabolic processes. It exhibits biological activity, although its precise mechanisms are still being investigated. Research suggests that d-biotin-d-sulfoxide might play a role in regulating cell growth and differentiation, potentially acting as an anti-proliferative agent. Additionally, studies explore its potential therapeutic applications, particularly in cancer treatment and metabolic disorders. The compound's structure and biological activity make it a fascinating target for further research, aiming to elucidate its specific roles and explore its therapeutic potential.'

biotin sulfoxide : A sulfoxide that is the S-oxide of biotin. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID83833
CHEBI ID62193
SCHEMBL ID29598
MeSH IDM0067522

Synonyms (36)

Synonym
biotin sulfoxide
5-[(3as,4s,6ar)-2,5-dioxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid
5-[(3as,4s,6ar)-5-oxido-2-oxohexahydro-1h-thieno[3,4-d]imidazol-4-yl]pentanoic acid
biotin s-oxide
10406-89-0
CHEBI:62193
1h-thieno(3,4-d)imidazole-4-pentanoic acid, hexahydro-2-oxo-, 5-oxide, (3as,4s,5s,6ar)-
d-biotin-d-sulfoxide
71et0lk93w ,
unii-71et0lk93w
1h-thieno(3,4-d)imidazole-4-pentanoic acid, hexahydro-2-oxo-, 5-oxide, (3as-(3aalpha,4beta,5alpha,6aalpha))-
C20386
AKOS016011979
3376-83-8
biotin sulfoxide, (-)-
biotin, l-s-oxide
1h-thieno(3,4-d)imidazole-4-pentanoic acid, hexahydro-2-oxo-, 5-oxide, (3as,4s,5r,6ar)-
biotin l-sulfoxide [mi]
(-)-biotin sulfoxide
unii-hgg20tda94
biotin, 5-oxide, (-)-
hgg20tda94 ,
biotin l-sulfoxide
SCHEMBL29598
KCSKCIQYNAOBNQ-YBSFLMRUSA-N
23015-53-4
DS-7044
5-[(3as,4s,6ar)-5-oxido-2-oxohexahydro-1h-thieno[3,4-d]imidazol-4 -yl]pentanoic acid
biotin-l-sulfoxid
5-((3as,4s,6ar)-5-oxido-2-oxohexahydro-1h-thieno[3,4-d]imidazol-4-yl)pentanoic acid
5-((3as,4s,5s,6ar)-5-oxido-2-oxohexahydro-1h-thieno[3,4-d]imidazol-4-yl)pentanoic acid
A875198
D94969
(3as,4s,6ar)-4-(4-carboxybutyl)-2-oxohexahydro-1h-thieno[3,4-d]imidazol-5-ium-5-olate
DTXSID00908774
5-((3as,4s,5s,6ar)-5-oxido-2-oxohexahydro-1h-thieno[3,4-d]imidazol-4-yl)pentanoicacid

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
biotinsCompounds containing a biotin (5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid) skeleton.
sulfoxideAn organosulfur compound having the structure R2S=O or R2C=S=O (R =/= H).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (22.22)18.7374
1990's8 (44.44)18.2507
2000's4 (22.22)29.6817
2010's0 (0.00)24.3611
2020's2 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.77

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.77 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.72 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.77)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]